Back to Virginia

HB736 • 2026

Health insurance; required provisions regarding prior authorization for prescription drugs.

An Act to amend and reenact § 38.2-3407.15:2, as it shall become effective, of the Code of Virginia, relating to health insurance; carrier contracts; required provisions regarding prior authorization for prescription drugs.

Enacted

This bill passed the Legislature and reached final enactment based on the latest official action.

Sponsor
Maldonado
Last action
2026-04-06
Official status
Acts of Assembly Chapter
Effective date
Not listed

Plain English Breakdown

The official source material does not support the claim about honoring prior authorizations from other insurers for more than 90 days after switching health plans.

Health Insurance Rules for Prescription Drugs

This act changes Virginia's health insurance laws to require a minimum duration of prior authorization and stricter conditions under which health insurers can revoke or limit approved prescription drugs.

What This Bill Does

  • Extends the minimum duration of prior authorization from six months to one year for initial authorizations, and from twelve months to two years for continued authorizations.
  • Adds new reasons why a health insurance company can revoke or limit an approved drug, such as safety concerns from FDA or manufacturers.
  • Requires health insurers to communicate with doctors about changes in drug approvals within specific time frames.

Who It Names or Affects

  • Health insurance companies
  • Doctors and patients who need prescription drugs

Terms To Know

Prior authorization
The process where a health insurer must approve a drug before it can be prescribed.
Supplementation
When an insurance company asks for more information to decide if they will cover a prescription drug.

Limits and Unknowns

  • The bill does not specify what happens if someone switches health plans after the initial 90 days.
  • It is unclear how this act will affect people who need drugs urgently and do not have prior authorization.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

HB736AHC1

2026-02-04 • Committee

Subcommittee #1 Subcommittee Amendment

Plain English: The amendment changes the requirements for prior authorization of prescription drugs by health insurance carriers.

  • Removes a requirement that there be a minimum duration for authorizations and instead sets a lower limit on how long an authorization can last.
  • Adds 'and efficacy' after 'safety' when considering whether to approve a drug.
  • Inserts 'clinically appropriate or' before 'is' to clarify the criteria for approving drugs.
  • The exact impact of these changes on how long prior authorizations will last is not clear from the amendment text alone.
HB736AH1

2026-02-05 • Committee

Labor and Commerce Amendment

Plain English: The amendment changes the requirements for prior authorization of prescription drugs by health insurance carriers in Virginia.

  • Removes a requirement that there be a minimum duration for prior authorizations and instead sets a specific duration for these authorizations.
  • Adds 'and efficacy' after 'safety' when considering factors for prior authorization.
  • Inserts 'clinically appropriate or' before 'is' to clarify the criteria for determining if a drug is clinically necessary.
  • The amendment text does not provide clear details on what specific duration will be set for authorizations, leaving this aspect undefined.

Bill History

  1. 2026-04-06 Governor

    Approved by Governor-Chapter 213 (effective 7/1/2026)

  2. 2026-04-06 Governor

    Approved by Governor-Chapter 213 (effective 7/1/2026)

  3. 2026-04-06 Governor

    Acts of Assembly Chapter text (CHAP0213)

  4. 2026-03-14 House

    Enrolled Bill communicated to Governor on March 14, 2026

  5. 2026-03-14 Governor

    Governor's Action Deadline 11:59 p.m., April 13, 2026

  6. 2026-03-12 House

    Signed by Speaker

  7. 2026-03-12 Senate

    Signed by President

  8. 2026-03-12 House

    Fiscal Impact Statement from Department of Planning and Budget (HB736)

  9. 2026-03-12 House

    Enrolled

  10. 2026-03-12 House

    Bill text as passed House and Senate (HB736ER)

  11. 2026-03-05 Senate

    Read third time

  12. 2026-03-05 Senate

    Read third time

  13. 2026-03-05 Senate

    Passed Senate Block Vote (39-Y 0-N 0-A)

  14. 2026-03-04 Senate

    Rules suspended

  15. 2026-03-04 Senate

    Passed by for the day

  16. 2026-03-04 Senate

    Constitutional reading dispensed Block Vote (on 2nd reading) (39-Y 0-N 0-A)

  17. 2026-03-04 Senate

    Passed by for the day Block Vote (Voice Vote)

  18. 2026-03-02 Commerce and Labor

    Reported from Commerce and Labor (13-Y 0-N)

  19. 2026-02-18 Senate

    Constitutional reading dispensed (on 1st reading)

  20. 2026-02-18 Commerce and Labor

    Referred to Committee on Commerce and Labor

  21. 2026-02-17 House

    Fiscal Impact Statement from Department of Planning and Budget (HB736)

  22. 2026-02-17 House

    Read third time and passed House Block Vote (97-Y 0-N 0-A)

  23. 2026-02-16 House

    Read second time

  24. 2026-02-16 House

    committee amendments agreed to

  25. 2026-02-16 House

    Engrossed by House as amended

  26. 2026-02-15 House

    Read first time

  27. 2026-02-13 Appropriations

    Reported from Appropriations (22-Y 0-N)

  28. 2026-02-13 Compensation and Retirement

    Subcommittee recommends reporting (7-Y 0-N)

  29. 2026-02-05 Compensation and Retirement

    Assigned HAPP sub: Compensation and Retirement

  30. 2026-02-05 Labor and Commerce

    Reported from Labor and Commerce with amendment(s) and referred to Appropriations (22-Y 0-N)

  31. 2026-02-03 Subcommittee #1

    Subcommittee recommends reporting with amendment(s) and referring to Appropriations (9-Y 0-N)

  32. 2026-01-20 Subcommittee #1

    Assigned HCL sub: Subcommittee #1

  33. 2026-01-13 House

    Prefiled and ordered printed; Offered 01-14-2026 26105188D

  34. 2026-01-13 Labor and Commerce

    Referred to Committee on Labor and Commerce

Official Summary Text

Health insurance; carrier contracts; required provisions regarding prior authorization for prescription drugs.
Amends existing required provisions for health carrier contracts related to prior authorizations for prescription drugs. Current law requires that if prior authorization is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, health carriers may not revoke, limit, condition, modify, or restrict that authorization except in certain circumstances. The bill requires this limitation on carriers to apply for the duration of the authorization, which the bill requires to be a minimum of six months for initial authorizations and a minimum of 12 months for continued authorizations. The bill adds circumstances under which a prior authorization may be revoked, limited, conditioned, modified, or restricted by a carrier, including (i) a final action by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer communicating a patient efficacy issue that would affect the authorization and (ii) when additional safety and efficacy monitoring is clinically appropriate or recommended by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer.

Current Bill Text

Read the full stored bill text
An Act to amend and reenact §
38.2-3407.15:2
, as it shall become effective, of the Code of Virginia, relating to health insurance; carrier contracts; required provisions regarding prior authorization for prescription drugs.
Be it enacted by the General Assembly of Virginia:
1. That §
38.2-3407.15:2
, as it shall become effective, of the Code of Virginia is amended and reenacted as follows:
§
38.2-3407.15:2
. (Effective January 1, 2027) Carrier contracts; required provisions regarding prior authorization for drug benefits.
A. As used in this section, unless the context requires a different meaning:
"Carrier" has the same meaning as provided in subsection A of §
38.2-3407.15
.
"Prior authorization" means the approval process used by a carrier before certain drug benefits may be provided.
"Provider contract" has the same meaning as provided in subsection A of §
38.2-3407.15
.
"Supplementation" means a request communicated by the carrier to the prescriber or his designee for additional information, limited to items specifically requested on the applicable prior authorization request, necessary to approve or deny such request.
B. Any provider contract between a carrier and a participating health care provider with prescriptive authority, or its contracting agent, shall contain specific provisions that:
1. Require the carrier to, in a method of its choosing, accept telephonic, facsimile, or electronic submission of prior authorization requests that are delivered from e-prescribing systems, electronic health record systems, and health information exchange platforms that utilize the National Council for Prescription Drug Programs' SCRIPT standards;
2. Require that the carrier communicate to the prescriber or his designee within 24 hours, including weekend hours, of submission of an urgent prior authorization request to the carrier, if submitted telephonically or in an alternate method directed by the carrier, that the request is approved, denied, or requires supplementation;
3. Require that the carrier communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within two business days of submission of a fully completed prior authorization request, that the request is approved, denied, or requires supplementation;
4. Require that the carrier communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within two business days of submission of a properly completed supplementation from the prescriber or his designee, that the request is approved or denied;
5. Require that if a prior authorization request is approved for prescription drugs and such prescription drugs have been scheduled, provided, or delivered to the patient consistent with the authorization, the carrier shall not
, for the duration of the authorization, which shall be no less than six months for initial authorizations and 12 months for continued authorizations,
revoke, limit, condition, modify, or restrict that authorization unless (i) there is evidence that the authorization was obtained based on fraud or misrepresentation; (ii) final actions by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer remove the drug from the market, limit its use in a manner that affects the authorization, or communicate a patient safety
or efficacy
issue that would affect the authorization alone or in combination with other authorizations; (iii)
additional safety and efficacy

monitoring is clinically appropriate or

recommended by the U.S. Food and Drug Administration, other regulatory agencies, or the manufacturer; (iv)
a combination of drugs prescribed would cause a drug interaction; or
(iv)
(v)
a generic or biosimilar is added to the prescription drug formulary. Nothing in this section shall require a carrier to cover any benefit not otherwise covered or cover a prescription drug if the enrollee is no longer covered by a health plan on the date the prescription drug was scheduled, provided, or delivered;
6. Require that if the prior authorization request is denied, the carrier shall communicate electronically, telephonically, or by facsimile to the prescriber or his designee, within the timeframes established by subdivision 3 or 4, as applicable, the reasons for the denial;
7. Require that prior authorization approved by another carrier be honored, upon the carrier's receipt from the prescriber or his designee of a record demonstrating the previous carrier's prior authorization approval or any written or electronic evidence of the previous carrier's coverage of such drug, at least for the initial 90 days of a member's prescription drug benefit coverage under a new health plan, subject to the provisions of the new carrier's evidence of coverage and any exception listed in subdivision 5;
8. Require that a tracking system be used by the carrier for all prior authorization requests and that the identification information be provided electronically, telephonically, or by facsimile to the prescriber or his designee, upon the carrier's response to the prior authorization request;
9. Require that the carrier's prescription drug formularies, all drug benefits subject to prior authorization by the carrier, all of the carrier's prior authorization procedures, and all prior authorization request forms accepted by the carrier be made available through one central location on the carrier's website and that such information be updated by the carrier within seven days of approved changes;
10. Require a carrier to honor a prior authorization issued by the carrier for a drug, other than an opioid, regardless of changes in dosages of such drug, provided such drug is prescribed consistent with U.S. Food and Drug Administration-labeled dosages;
11. Require a carrier to honor a prior authorization issued by the carrier for a drug regardless of whether the covered person changes plans with the same carrier and the drug is a covered benefit with the current health plan;
12. Require a carrier, when requiring a prescriber to provide supplemental information that is in the covered individual's health record or electronic health record, to identify the specific information required;
13. Require that no prior authorization be required for at least one drug prescribed for substance abuse medication-assisted treatment, provided that (i) the drug is a covered benefit, (ii) the prescription does not exceed the FDA-labeled dosages, and (iii) the drug is prescribed consistent with the regulations of the Board of Medicine;
14. Require that when any carrier has previously approved prior authorization for any drug prescribed for the treatment of a mental disorder listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association, no additional prior authorization shall be required by the carrier, provided that (i) the drug is a covered benefit; (ii) the prescription does not exceed the FDA-labeled dosages; (iii) the prescription has been continuously issued for no fewer than three months; and (iv) the prescriber performs an annual review of the patient to evaluate the drug's continued efficacy, changes in the patient's health status, and potential contraindications. Nothing in this subdivision shall prohibit a carrier from requiring prior authorization for any drug that is not listed on its prescription drug formulary at the time the initial prescription for the drug is issued;
15. Require a carrier to honor a prior authorization issued by the carrier for a drug regardless of whether the drug is removed from the carrier's prescription drug formulary after the initial prescription for that drug is issued, provided that the drug and prescription are consistent with the applicable provisions of subdivision 14;
16. Require a carrier, beginning July 1, 2025, notwithstanding the provisions of subdivision 1 or any other provision of this section, to establish and maintain an online process that (i) links directly to all e-prescribing systems and electronic health record systems that utilize the National Council for Prescription Drug Programs SCRIPT standard and the National Council for Prescription Drug Programs Real Time Benefit Standard; (ii) can accept electronic prior authorization requests from a provider; (iii) can approve electronic prior authorization requests (a) for which no additional information is needed by the carrier to process the prior authorization request, (b) for which no clinical review is required, and (c) that meet the carrier's criteria for approval; (iv) links directly to real-time patient out-of-pocket costs for the prescription drug, considering copayment and deductible; and (v) otherwise meets the requirements of this section. No carrier shall (a) impose a fee or charge on any person for accessing the online process as required by this subdivision or (b) access, absent provider consent, provider data via the online process other than for the enrollee. No later than July 1, 2024, a carrier shall provide contact information of any third-party vendor or other entity the carrier will use to meet the requirements of this subdivision or the requirements of §
38.2-3407.15:7
to any provider that requests such information. A carrier that posts such contact information on its website shall be considered to have met this requirement; and
17. Require a participating health care provider, beginning July 1, 2025, to ensure that any e-prescribing system or electronic health record system owned by or contracted for the provider to maintain an enrollee's health record has the ability to access, at the point of prescribing, the electronic prior authorization process established by a carrier as required by subdivision 16 and the real-time patient-specific benefit information, including out-of-pocket costs and more affordable medication alternatives made available by a carrier pursuant to §
38.2-3407.15:7
. A provider may request a waiver of compliance under this subdivision for undue hardship for a period specified by the appropriate regulatory authority with the Health and Human Resources Secretariat.
C. The Commission shall have no jurisdiction to adjudicate individual controversies arising out of this section.
D. This section shall apply with respect to any contract between a carrier and a participating health care provider or its contracting agent that is entered into, amended, extended, or renewed on or after January 1, 2016.
E. Notwithstanding any law to the contrary, the provisions of this section shall not apply to:
1. Coverages issued pursuant to Title XVIII of the Social Security Act, 42 U.S.C. § 1395 et seq. (Medicare), Title XIX of the Social Security Act, 42 U.S.C. § 1396 et seq. (Medicaid), Title XXI of the Social Security Act, 42 U.S.C. § 1397aa et seq. (CHIP), 5 U.S.C. § 8901 et seq. (federal employees), or 10 U.S.C. § 1071 et seq. (TRICARE);
2. Accident only, credit or disability insurance, long-term care insurance, TRICARE supplement, Medicare supplement, or workers' compensation coverages;
3. Any dental services plan or optometric services plan as defined in §
38.2-4501
; or
4. Any health maintenance organization that (i) contracts with one multispecialty group of physicians who are employed by and are shareholders of the multispecialty group, which multispecialty group of physicians may also contract with health care providers in the community; (ii) provides and arranges for the provision of physician services by such multispecialty group physicians or by such contracted health care providers in the community; and (iii) receives and processes at least 85 percent of prescription drug prior authorization requests in a manner that is interoperable with e-prescribing systems, electronic health records, and health information exchange platforms.
2. That the provisions of this act shall apply to contracts entered into, amended, or renewed on or after January 1, 2027.